Abeona Therapeutics Inc. (ABEO) — 8-K Filings

8-K Filings (14)

• 8-K Filing — Apr 7, 2026
• Abeona Therapeutics Enters Material Definitive Agreement — Jul 18, 2025 Risk: medium
  On July 18, 2025, Abeona Therapeutics Inc. entered into a material definitive agreement, creating a direct financial obligation. The company, formerly known as
• Abeona Therapeutics Completes Asset Acquisition — Jul 2, 2025 Risk: medium
  On June 27, 2025, Abeona Therapeutics Inc. reported the completion of its acquisition of the assets of a company, though the specific name and financial details
• Abeona Therapeutics Files 8-K on Security Holder Vote — May 19, 2025 Risk: low
  On May 19, 2025, Abeona Therapeutics Inc. filed an 8-K report indicating that it submitted matters to a vote of its security holders. The filing does not specif
• Abeona Therapeutics Files 8-K with Material Agreement — May 12, 2025 Risk: medium
  On May 9, 2025, Abeona Therapeutics Inc. entered into a material definitive agreement. The company also reported other events and filed financial statements and
• Abeona Therapeutics Files 8-K Report — Apr 29, 2025 Risk: low
  On April 29, 2025, Abeona Therapeutics Inc. filed an 8-K report. The filing primarily concerns "Other Events" and "Financial Statements and Exhibits," indicatin
• Abeona Therapeutics Announces Board Changes and Officer Appointments — Dec 20, 2024 Risk: medium
  On December 20, 2024, Abeona Therapeutics Inc. filed an 8-K report detailing several key events. The company announced the election of new directors, including
• Abeona Therapeutics Files 8-K Report — Oct 29, 2024 Risk: low
  On October 28, 2024, Abeona Therapeutics Inc. filed an 8-K report. The filing primarily concerns "Other Events" and "Financial Statements and Exhibits," indicat
• Abeona Therapeutics Inc. Announces Board Changes — Aug 14, 2024 Risk: low
  On August 8, 2024, Abeona Therapeutics Inc. announced changes to its Board of Directors, including the election of Dr. Carsten Brunn and Ms. Jennifer D. Johnson
• Abeona Therapeutics Files 8-K for Bylaw Amendments — Jul 9, 2024 Risk: low
  On July 5, 2024, Abeona Therapeutics Inc. filed an 8-K report detailing amendments to its articles of incorporation and bylaws. The company, incorporated in Del
• Abeona Therapeutics Closes $178.8M Public Offering — May 3, 2024 Risk: medium
  On May 2, 2024, Abeona Therapeutics Inc. announced the closing of its previously disclosed underwritten public offering. The company successfully sold approxima
• Abeona Therapeutics Appoints New CFO, Elects Directors — Apr 24, 2024 Risk: medium
  On April 24, 2024, Abeona Therapeutics Inc. filed an 8-K report detailing several key events. The company announced the election of new directors, including Dr.
• Abeona Therapeutics Files 8-K Report — Apr 22, 2024 Risk: low
  On April 22, 2024, Abeona Therapeutics Inc. filed an 8-K report. The filing primarily concerns "Other Events" and "Financial Statements and Exhibits," indicatin
• Abeona Therapeutics Reports Material Agreement & New Financial Obligation — Jan 8, 2024
  On January 8, 2024, Abeona Therapeutics Inc. filed an 8-K to report an "Entry into a Material Definitive Agreement" and the "Creation of a Direct Financial Obli

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX